Filing Details

Accession Number:
0001079973-20-000644
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-07 19:23:34
Reporting Period:
2020-08-04
Accepted Time:
2020-08-07 19:23:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1128189 Protokinetix Inc. PKTX Pharmaceutical Preparations (2834) 943355026
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1516077 Edward Clarence Smith 1845 County Road #214
St. Augustine FL 32084
President & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-04 27,500,000 $0.00 27,911,110 No 4 G Direct
Common Stock Acquisiton 2020-08-04 1,000,000 $0.07 28,911,110 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,235,160 Indirect See footnote
Common Stock 1,850,000 Indirect See footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $0.14 2026-03-25 5,000,000 5,000,000 Direct
Common Stock Stock Option $0.14 2026-03-25 5,000,000 5,000,000 Direct
Common Stock Warrant $0.12 2019-12-19 2022-12-18 216,666 216,666 Direct
Common Stock Stock Option $0.11 2024-11-17 5,000,000 5,000,000 Direct
Common Stock Stock Option $0.26 2024-07-14 5,000,000 5,000,000 Direct
Common Stock Stock Option $0.09 2023-11-08 5,000,000 5,000,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-03-25 5,000,000 5,000,000 Direct
2026-03-25 5,000,000 5,000,000 Direct
2022-12-18 216,666 216,666 Direct
2024-11-17 5,000,000 5,000,000 Direct
2024-07-14 5,000,000 5,000,000 Direct
2023-11-08 5,000,000 5,000,000 Direct
Footnotes
  1. Bona fide gift to adult daughter for estate planning purposes. Mr. Smith disclaims any beneficial ownership of such shares through his daughter.
  2. Shares purchased in a private placement from the Company.
  3. Shares held by the Clarence E. Smith Trusts.
  4. Shares held by Mr. Smith's retirement account.
  5. Options issued pursuant to the Company's Amended 2017 Stock Option and Stock Bonus Plan on March 26, 2020. Fully vested.
  6. Options issued pursuant to the Company's Amended 2017 Stock Option and Stock Bonus Plan on November 18, 2019. 1,250,000 shares of common stock vest on February 18, 2020; thereafter 1,250,000 shares vest every three months until fully vested on November 18, 2020.
  7. Options issued pursuant to the Company's Amended 2017 Stock Option and Stock Bonus Plan on July 15, 2019. 1,250,000 shares of common stock vest on October 13, 2019; thereafter 1,250,000 shares vest every three months until fully vested on July 13, 2020.
  8. Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on November 9, 2018. On March 31, 2019, 1,250,000 shares vest; thereafter 1,250,000 shares vest each quarter.